Astellas Pharma Inc., of Tokyo, appointed Nahrin Marino vice president, head of Ethics & Compliance, Americas, effective July 15. Previously, Marino served as Astellas' deputy general counsel, Regulatory. Prior to joining the company in 2010, she worked at Dykema Gossett, representing corporations in pharmaceutical and medical device litigation.

JHL Biotech Co. Ltd., of Hsinchu, Taiwan, appointed Ellis Chu chief financial officer. Chu most recently served as a managing director and the head of greater China at Ion Pacific, an Asia-focused venture capital merchant bank. Prior to that, Ellis spent the bulk of his career in investment banking, including head of China mergers and acquisitions at Bank of America Merrill Lynch.

Sumitomo Dainippon Pharma Co. Ltd., of Osaka, Japan, appointed Tetsuya Uyama, senior officer, legal disputes and Hiroshi Kishimoto, senior director, legal affairs, both effective July 1.